Fondaparinux Sodium 7.5 mg/.6mL

Fondaparinux Sodium 7.5 mg/0.6mL is an injectable medication used for blood clot prevention and treatment. This subcutaneous injection is manufactured by Sandoz Inc. in the USA.

Fondaparinux Sodium is primarily used to prevent and treat blood clots, such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It is often administered to patients undergoing certain types of surgery or those at risk of blood clots. The medication works by inhibiting the formation of clots in the blood vessels, helping to maintain proper blood flow.

Common effects of Fondaparinux Sodium may include bruising, bleeding, and pain at the injection site. Some individuals might experience allergic reactions, though these are less frequent. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Fondaparinux Sodium should be handled with care, ensuring proper storage and administration. It is crucial to follow the prescribed guidelines for subcutaneous injection to minimize the risk of complications. Patients with a history of bleeding disorders or recent surgery should use this medication under medical supervision.

Fondaparinux Sodium may interact with other blood-thinning medications, nonsteroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics. Alcohol consumption should be moderated, as it can increase the risk of bleeding. Always inform healthcare providers about all medications being taken to avoid potential interactions.